Correlation Between Samsung Electronics and INtRON Biotechnology
Can any of the company-specific risk be diversified away by investing in both Samsung Electronics and INtRON Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Electronics and INtRON Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Electronics Co and iNtRON Biotechnology, you can compare the effects of market volatilities on Samsung Electronics and INtRON Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Electronics with a short position of INtRON Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Electronics and INtRON Biotechnology.
Diversification Opportunities for Samsung Electronics and INtRON Biotechnology
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Samsung and INtRON is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Electronics Co and iNtRON Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iNtRON Biotechnology and Samsung Electronics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Electronics Co are associated (or correlated) with INtRON Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iNtRON Biotechnology has no effect on the direction of Samsung Electronics i.e., Samsung Electronics and INtRON Biotechnology go up and down completely randomly.
Pair Corralation between Samsung Electronics and INtRON Biotechnology
Assuming the 90 days trading horizon Samsung Electronics Co is expected to under-perform the INtRON Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Samsung Electronics Co is 1.42 times less risky than INtRON Biotechnology. The stock trades about -0.09 of its potential returns per unit of risk. The iNtRON Biotechnology is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 591,000 in iNtRON Biotechnology on September 13, 2024 and sell it today you would lose (35,000) from holding iNtRON Biotechnology or give up 5.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Samsung Electronics Co vs. iNtRON Biotechnology
Performance |
Timeline |
Samsung Electronics |
iNtRON Biotechnology |
Samsung Electronics and INtRON Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Samsung Electronics and INtRON Biotechnology
The main advantage of trading using opposite Samsung Electronics and INtRON Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Electronics position performs unexpectedly, INtRON Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INtRON Biotechnology will offset losses from the drop in INtRON Biotechnology's long position.Samsung Electronics vs. Korea Air Svc | Samsung Electronics vs. Display Tech Co | Samsung Electronics vs. PLAYWITH | Samsung Electronics vs. Chorokbaem Healthcare Co |
INtRON Biotechnology vs. Medy Tox | INtRON Biotechnology vs. Oscotec | INtRON Biotechnology vs. Genexine | INtRON Biotechnology vs. Helixmith Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |